Dr. Peddi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3445 Pacific Coast Hwy
Ste 300
Torrance, CA 90505Phone+1 310-325-8252Fax+1 310-794-1699
Summary
- Dr. Parvin Peddi is an oncologist in Santa Monica, CA and is affiliated with Providence Saint John's Health Center. She received her medical degree from Duke University School of Medicine and has been in practice 11 years. She also speaks multiple languages, including Farsi. She is a breast cancer specialist and runs clinical trials for patients with breast cancer. She has more than 20 publications and over 500 citings.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2013
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2010 - 2012- Washington University/B-JH/SLCH ConsortiumChief Residency, Internal Medicine, 2009 - 2010
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
Duke University School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2012 - 2026
MO State Medical License Active through 2013- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 85 citationsMulti-Institutional experience with FOLFIRINOX in pancreatic adenocarcinomaParvin F. Peddi, Sam J. Lubner, Robert R. McWilliams, Benjamin R. Tan, Joel Picus
JOP. 2012-09-10 - 50 citationsAdo-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential.Parvin F. Peddi, Sara A. Hurvitz
Therapeutic Advances in Medical Oncology. 2014-06-19 - 17 citationsNab-paclitaxel monotherapy in refractory pancreatic adenocarcinomaParvin F. Peddi, May Cho, Jian Wang, Feng Gao, Andrea Wang-Gillam
Journal of Gastrointestinal Oncology. 2013-03-06
Press Mentions
How Do Hormonal IUDs Affect Breast Cancer Risk?October 22nd, 2024
Four Myths About Breast Cancer DebunkedOctober 10th, 2018
Breast Cancer Symptoms to Look Out ForDecember 7th, 2017- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
